Value Aligned Research Advisors’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.8M Buy
163,900
+150,400
+1,114% +$56.4M 0.15% 71
2026
Q1
$3.8M Hold
13,500
0.02% 91
2025
Q4
$3.99M Hold
13,500
0.04% 73
2025
Q3
$3.33M Hold
13,500
0.04% 71
2025
Q2
$2.11M Buy
13,500
+5,500
+69% +$585K 0.04% 60
2025
Q1
$630K Sell
8,000
-1,600
-17% -$170K 0.05% 52
2024
Q4
$125K Buy
+9,600
New +$751K 0.03% 38
2024
Q3
Sell
-500
Closed -$3.53K 24
2024
Q2
$3.53K Buy
+500
New +$25.2K ﹤0.01% 28

Other funds holding CLS

Value Aligned Research Advisors's CLS Position: Q2 2026 in Review

Value Aligned Research Advisors increased its Celestica (CLS) stake by 5.7% in Q2 2026, buying an estimated $31.9M and bringing the position to 1,576,402 shares worth $575M. The position accounts for 1.43% of the portfolio, ranked #20.

Value Aligned Research Advisors first reported a position in CLS in Q2 2024 and has held it in 9 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Value Aligned Research Advisors held 1,576,402 shares of Celestica worth $575M as of Q2 2026.
  • Value Aligned Research Advisors bought 84,908 Celestica shares in Q2 2026, an estimated $31.9M.
  • Celestica made up 1.43% of Value Aligned Research Advisors's portfolio in Q2 2026, its #20 holding.
  • Value Aligned Research Advisors first reported a position in Celestica in Q2 2024 and has held it in 9 quarters since.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Value Aligned Research Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.